Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer.
Tian DuMatthew J SikoraKevin M LevineNilgun TasdemirRebecca B RigginsStacy G WendellBennett Van HoutenSteffi OesterreichPublished in: Breast cancer research : BCR (2018)
Our characterization of a unique series of AI-resistant ILC models identifies the activation of key regulators of fatty acid and cholesterol metabolism, implicating lipid-metabolic processes driving estrogen-independent growth of ILC cells. Targeting these changes may prove a strategy for prevention and treatment of endocrine resistance for patients with ILC.